Sellbyville, DE -- (SBWIRE) -- 04/30/2019 -- Point of Care Testing Market size is set to exceed USD 34.2 billion by 2024; according to a new research study published by Global Market Insights, Inc. Increase in number of pathology labs and services equipped with advanced diagnostic equipment in North America will be one of the major factors driving the growth of POC testing market. Healthcare infrastructure development has resulted in the industry growth. Majority of the population staying in developed countries rely on healthcare facilities developed by the public healthcare sector, that will positively impact the industry growth.

Molecular diagnostics holds significant role in the field of microbiology. Conventional culture method is not helpful in obtaining timely results. Molecular testing technology allows nucleic acid detection directly through amplification and screening of sample. Real time PCR is used for this purpose. Industry players have been focusing their efforts on developing new point of care molecular diagnostic technologies to deliver faster results with high accuracy and specificity. Hence, increase in research and development will augment the market growth in the forthcoming years.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/3086

High cost of the tests and the devices will be one of the major market hampering factors. The biomolecules used in developing point of care tests are complex in nature and expensive. Hence, the aforementioned factors will hinder the market growth.

Pregnancy and fertility testing products market held a significant amount of market share in the year 2017 and was valued around USD 2,384.7 million. Factors such as heredity, late child bearing and changing lifestyles are the major risk factors that lead to infertility. Hence, increase in number of infertility cases will significantly contribute to assisted reproductive technology market growth in forthcoming years.

Solid phase technology market is estimated to witness a growth of 9.2% during the forecast time period. Presence of HIV antibodies will result in a spot or dot with the help of a signal reagent. Such tests have high sensitivity and are designed to aid in the diagnosis of diseases along with the determination of antibody levels, thereby driving the segmental growth.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/3086

Prescription-based testing market was valued around USD 8,640.0 million in the year 2017. Diagnostic uncertainty escalates the risk of unnecessary antibiotic prescribing hence point of care testing is considered as key to rational prescribing. Issuance of such guidelines favoring use of point of care testing will drive segmental growth over the forecast timeframe.

The use of point of care testing devices in nephrology testing is projected to grow at a CAGR of 7.4% during the estimation period. Increasing incidence of kidney failure and kidney diseases will stimulate demand for nephrology testing over the forecast period. Rising number of people suffering from diabetes, high blood pressure, obesity, and other risk factors such as smoking leading to kidney diseases will fuel demand for nephrology testing over the forecast timeframe.

Germany dominated the Europe POC testing market and was valued around USD 1,717.4 million in the year 2017. In the Federal Republic of Germany, point-of-care systems are increasingly used within hospitals and medical practices. Other medical facilities where point of care testing is widely used includes outpatient nursing care, pharmacies and home visits. Therefore, growing adoption of point of care testing across the nation will drive the regional market growth.

Japan POC testing market is projected to grow at a CAGR of 8.7% over the projection period. As per the statistics published by the World Health Organization (WHO), more than 20,000 people were suffering from HIV and tuberculosis in Japan in the year 2016. This rising incidence stimulates the demand for point of care diagnostics tests resulting in growing demand and adoption rate of point of care testing devices in the country.

Major companies operating in the POC testing market include Abbott, F. Hoffmann-La Roche Ltd., Johnson and Johnson, Siemens AG, and Abaxis, among others. The company's major strategy includes launching of technologically advanced new and innovative products. Industry participants are also focusing on product portfolio expansion to suit the requirements of different healthcare settings in terms of test volumes, assay menu and budget to stay ahead of the competition.

Point of care testing market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2013 to 2024, for the following segments:

POC testing market by Product
- Glucose monitoring
o Strips
o Meters
o Lancets
- Cardiometabolic testing products
o Cardiac marker testing products
o Blood Gas/Electrolytes testing products
o HBA1C testing products
- Infectious disease testing products
o Influenza testing products
o HIV testing products
o Hepatitis C testing products
o Sexually Transmitted Disease (STD) testing products
o Healthcare-Associated Infection (HAI) testing products
o Respiratory infection testing products
o Tropical disease testing products
o Other infectious diseases testing products
- Coagulation testing products
o PT/INR testing products
o Activated Clotting Time (ACT/APTT) testing products
- Pregnancy and fertility testing products
o Pregnancy testing products
o Fertility testing products
- Tumor/Cancer marker testing products
- Urinalysis testing products
- Cholesterol testing products
- Hematology testing products
- Drug-of-Abuse (DoA) testing products
- Fecal occult testing products
- Other products
POC testing market by Technology
- Lateral flow assays
- Dipsticks
- Microfluidics
- Molecular diagnostics
- Immunoassays
- Agglutination assays
- Flow-Through
- Solid phase
- Biosensors
POC testing market by Prescription
- OTC testing
- Prescription-based testing
POC testing market by Application
- Cardio metabolic testing
- Infectious disease testing
- Nephrology testing
- Drug-of-Abuse (DoA) testing
- Blood glucose testing
- Pregnancy testing
- Cancer biomarker testing
- Other applications
POC testing market by End-use
- Hospitals
- Diagnostic centers
- Research laboratories
- Home-care settings
- Other end-uses

The above information is provided for the following regions/countries:
- North America
o U.S.
o Canada
- Europe
o Germany
o UK
o France
o Spain
o Italy
- Asia Pacific
o China
o Japan
o India
o Australia
- Latin America
o Brazil
o Mexico
- Middle East and Africa
o South Africa
o Saudi Arabia